BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2017
View Archived Issues
FDA grants orphan drug status to ADC Therapeutics' ADCT-402
Read More
Dragonfly Therapeutics enters strategic collaboration with Celgene
Read More
Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa
Read More
Coherus BioSciences receives complete response letter from FDA for CHS-1701
Read More
Spero Therapeutics gives update on development of antibacterial agents
Read More
Gilead Sciences submits NDA in U.S. for bictegravir/emtricitabine/tenofovir alafenamide
Read More
FDA grants rare pediatric disease designation to Fibrocell Science's FCX-013
Read More
SLC6A6 gene variant linked to vision loss is possibly amenable to nutritional therapy
Read More
Numerate to identify clinical candidates for Takeda using AI-driven platform
Read More
Update on Pieris Pharmaceuticals' collaboration agreement with AstraZeneca
Read More
Seres initiates phase III study of SER-109 in recurrent C. difficile infection
Read More
New clinical outcomes trial of Jardiance planned in chronic kidney disease
Read More
Sunshine Lake Pharma discloses orexin OX1 and OX2 receptor antagonists
Read More
Phase II DART study of dalantercept plus axitinib in RCC misses primary endpoint
Read More
Medshine Discovery patents IL-6 release inhibitors
Read More
Roche discovers cathepsin S inhibitors
Read More
Alkermes begins phase IIIb study of ALKS-5461 for adjunctive treatment of major depressive disorder
Read More
FDA accepts Bioverativ's IND for BIVV-001 for hemophilia A
Read More
Genentech and Roche identify JAK inhibitors
Read More
Blueprint Medicines discloses neurotrophic tyrosine kinase receptors inhibitors
Read More
Aimmune updates progress of phase III PALISADE trial of AR-101 in peanut allergy
Read More
Rotary and Bill & Melinda Gates Foundation announce commitment to eradicate polio
Read More
Final overall survival data reported for phase III trial of cediranib in ovarian cancer
Read More
Final data for talazoparib in BRCA-mutated breast cancer
Read More